|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01262 LABIXIAOXIN
Nominal 
1.940 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 88,641 | 15,462 | (135,290) | (12,466) |
| Net Cash from / (used in) Investing Activities | -- | (32,892) | 55,938 | 113,424 | 300,931 |
| Net Cash from / (used in) Financing Activities | -- | (83,306) | (80,091) | (156,406) | (54,459) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (27,557) | (8,691) | (178,272) | 234,006 |
| Cash & Cash Equivalents at beginning of period | -- | 71,876 | 80,567 | 258,839 | 24,833 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 | 0 | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 44,319 | 71,876 | 80,567 | 258,839 |
| Remarks: | Real time quote last updated: 11/11/2024 10:08 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -43,645,000 |
| %Change | 803.249% |
| EPS / (LPS) | RMB -0.330 |
| NBV Per Share (¥) | RMB 1.346 |